CClinicalTrials.gg
Status unknownNCT04930068Updated Jun 18, 2021

Ultrasonic Cavitation on Abdominal Obesity in Adolescent Females

An interventional study of low caloric diet in Ultrasonic, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to female participants aged 17 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-18.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
17 Years to 21 Years
Sex
Female
01

Study summary

The purpose of this study was to determine the effect of ultrasonic cavitation on abdominal obesity in females. Fifty volunteer females with abdominal obesity participated in the study.

Read the detailed description

The purpose of this study was to determine the effectiveness of ultrasonic cavitation on abdominal obesity in adolescent females. Fifty volunteer females with abdominal obesity participated in the study.

Group (A) consisted of 25 females who treated by ultrasonic cavitation on abdominal region for 30 minutes and aerobic exercises for 30 minutes, 2 times per week for 6 weeks ; group (B) consisted of 25 females who performed aerobic exercise and low caloric diet.

02

Conditions studied

  • Ultrasonic

Browse trials for

Keywords

  • Ultrasonic
  • aerobic exercise
  • Diet
03

In context

Obesity, Abdominal

274 studies on the registry are indexed under Obesity, Abdominal; 44 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 216 interventional studies indexed under Obesity, Abdominal.

Browse Obesity, Abdominal studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 21 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Their ages were range from 17 to 21 years old.
  • Their body mass index less than 35kg/m2.

Exclusion criteria

Exclusion Criteria:

  • Females with BMI exceed 35kg/m2.
  • Females have psychological disorders.
  • cardiac diseases.
  • hypertension
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    ultra-sound

    ultrasonic cavitation applied on abdominal region for 30 minutes, 2 times per week for 6 weeks.

    Other: low caloric diet

  • Experimental
    aerobic exercise

    aerobic exercises through treadmill (60-70% of VO2 max.) for 30 minutes, 2 times per week for 6 weeks

    Other: low caloric diet

Interventions

  • Otherlow caloric diet

    A low-calorie diet is a structured eating plan that restricts daily caloric intake, commonly for weight loss. Following a low-calorie diet typically means consuming around 1,200 to 1,500 calories per day, which creates a calorie deficit that can lead to weight loss. A low-calorie diet can be effective, but it requires a lot of discipline to work and be safe.

06

What researchers measure

Primary outcomes

  1. Bioelectrical impedance analysis

    was used to estimate body composition, in particular body fat and muscle mass, where a weak electric current flows through the body and the voltage is measured in order to calculate impedance (resistance) of the body. Most body water is stored in muscle in both groups A and B

    Time frame: 6 weeks

Secondary outcomes

  1. skin fold caliper

    was used to measure the waist circumference and amount of subcutaneous fat when the fold for all females in both groups (A\&B)

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04930068
Lead sponsor
Cairo University
Collaborators
Ghada ebrahim El Refaye - Department of Physical Therapy for Women's Health, Faculty of Physical Therapy, Cairo University, Egypt
Responsible party
Ghada Ebrahim El Refaye (assistant professor Department of Physical Therapy for Women's Health, Faculty of Physical therapy, Cairo University, Egypt, Cairo University) — Principal investigator
First posted
Jun 18, 2021
Start date
May 1, 2021
Primary completion
Jul 30, 2021 (estimated)
Completion
Jul 31, 2021 (estimated)
Last update
Jun 18, 2021

Study contacts

Ghada E Elrefaye, professor
Contact
ghadaebrahim2000@gmail.com
+201005572715 ext. 02
Ghada E Elrefaye, lecturer
Contact
ghadaebrahim2000@gmail.com
+201005572715 ext. 02
Ghada E Elrefaye, professor
principal investigator · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion